Gene · 9475
Papers3,801
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
381 to 400 of 3,801
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
Exploratory analysis to predict pneumonitis during durvalumab consolidation therapy for patients with locally advanced non-small cell lung cancer from proteomic profiling of circulating extracellular vesicles. | Thorac Cancer | 2023 | 37614219 | PubTator, text mining | PubMed |
| Real-world experience with low-dose IL-2 for children and young adults with refractory chronic graft-versus-host disease. | Blood Adv | 2023 | 37603347 | PubTator, text mining | PubMed |
Phase 3 Clinical Trial Comparing the Safety and Efficacy of Netarsudil to Ripasudil in Patients with Primary Open-Angle Glaucoma or Ocular Hypertension: Japan Rho Kinase Elevated Intraocular Pressure Treatment Trial (J-ROCKET). | Adv Ther | 2023 | 37603205 | PubTator, text mining | PubMed |
| ZXDC enhances cervical cancer metastasis through IGF2BP3-mediated activation of RhoA/ROCK signaling. | iScience | 2023 | 37599824 | PubTator, text mining | PubMed |
| MFAP2 promotes the progression of oral squamous cell carcinoma by activating the Wnt/β-catenin signaling pathway through autophagy. | Acta Biochim Biophys Sin (Shanghai) | 2023 | 37592847 | PubTator, text mining | PubMed |
| The impact of exosomes derived from distinct sources on rheumatoid arthritis. | Front Immunol | 2023 | 37575235 | PubTator, text mining | PubMed |
| Emerging Roles of Lysophosphatidic Acid in Macrophages and Inflammatory Diseases. | Int J Mol Sci | 2023 | 37569902 | PubTator, text mining | PubMed |
| Glucocorticoid Treatment in Acute Respiratory Distress Syndrome: An Overview on Mechanistic Insights and Clinical Benefit. | Int J Mol Sci | 2023 | 37569514 | PubTator, text mining | PubMed |
| Statins in Cancer Prevention and Therapy. | Cancers (Basel) | 2023 | 37568764 | PubTator, text mining | PubMed |
| Cordycepin (3'dA) Induces Cell Death of AC133+ Leukemia Cells via Re-Expression of WIF1 and Down-Modulation of MYC. | Cancers (Basel) | 2023 | 37568748 | PubTator, text mining | PubMed |
| Proteomic and Metabolomic Analysis of Bone Marrow and Plasma from Patients with Extramedullary Multiple Myeloma Identifies Distinct Protein and Metabolite Signatures. | Cancers (Basel) | 2023 | 37568580 | PubTator, text mining | PubMed |
| ZNF143 inhibits hepatocyte mitophagy and promotes non-alcoholic fatty liver disease by targeting increased lncRNA NEAT1 expression to activate ROCK2 pathway. | Epigenetics | 2023 | 37566742 | PubTator, text mining | PubMed |
| Transcriptomic analysis of mechanism underlying the effect of induced molting on semen quality and reproductive performance in aged Houdan roosters. | Poult Sci | 2023 | 37562133 | PubTator, text mining | PubMed |
| Resolving the role of podoplanin in the motility of papillary thyroid carcinoma-derived cells using RNA sequencing. | Comput Struct Biotechnol J | 2023 | 37560122 | PubTator, text mining | PubMed |
| Cytotoxicity of poly-guanidine in medulloblastoma cell lines. | Invest New Drugs | 2023 | 37556022 | PubTator, text mining | PubMed |
| Ocular surface disease: a known yet overlooked side effect of topical glaucoma therapy. | Front Toxicol | 2023 | 37547228 | PubTator, text mining | PubMed |
| Role of miR‑181a‑5p in cancer (Review). | Int J Oncol | 2023 | 37539738 | PubTator, text mining | PubMed |
| The therapeutic targets of N6-methyladenosine (m6A) modifications on tumor radioresistance. | Discov Oncol | 2023 | 37522921 | PubTator, text mining | PubMed |
| Corrigendum to: Acrolein, an endogenous aldehyde induces synaptic dysfunction in vitro and in vivo: Involvement of RhoA/ROCK2 pathway. | Aging Cell | 2023 | 37522269 | PubTator, text mining | PubMed |
| Cycloartane Saponins from Astragalus glycyphyllos and Their In Vitro Neuroprotective, Antioxidant, and hMAO-B-Inhibiting Effects. | Metabolites | 2023 | 37512564 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9475/papers?page=20